{
    "attributes": {
        "action": "Where a treatment exists, provide fair and fast access for rare disease patients",
        "additional_details": "The Department of Health, NICE and NHS England should work together with patient groups, clinical experts, and the Pharmaceutical Industry to establish a new and fair process for appraisal of rare disease medicines.\r\n\r\nData from the Report:\r\nEquity and Access: Making the UK a Rare Disease Leader. (2017) Initiated and funded by Shire Pharmaceuticals and developed in collaboration with an external steering group\r\n\r\nThis petition, and the Equity and Access Report, were initiated and funded by Shire.\r\n",
        "background": "People with rare diseases wait on average over 2 years for potentially life-changing treatments. Less than half of treatments approved in the last 15 years are funded by NHS England vs. 93% in Germany and 81% in France. If a treatment exists, access should be the same as for more common conditions.",
        "closed_at": "2017-05-02T23:01:00.000Z",
        "created_at": "2017-03-13T09:14:50.821Z",
        "debate": null,
        "debate_outcome_at": null,
        "debate_threshold_reached_at": null,
        "government_response": null,
        "government_response_at": null,
        "moderation_threshold_reached_at": "2017-03-13T09:55:45.741Z",
        "opened_at": "2017-03-22T12:03:01.794Z",
        "rejected_at": null,
        "rejection": null,
        "response_threshold_reached_at": null,
        "scheduled_debate_date": null,
        "signature_count": 7,
        "state": "closed",
        "updated_at": "2017-09-09T06:33:07.185Z"
    },
    "id": 190122,
    "links": {
        "self": "https://petition.parliament.uk/archived/petitions/190122.json"
    },
    "type": "archived-petition"
}